Cumberland Pharmaceuticals (CPIX) EBT Margin Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | -187,049.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -187,049.00 |
| Mar 31, 2026 | -3,630.00 |
| Dec 31, 2025 | 1,625.00 |
| Sep 30, 2025 | -1,979.00 |
| Jun 30, 2025 | 645.00 |
| Mar 31, 2025 | 2,319.00 |
| Dec 31, 2024 | 3,382.00 |
| Sep 30, 2024 | 273.00 |
| Jun 30, 2024 | -1,916.00 |
| Mar 31, 2024 | -1,900.00 |
| Dec 31, 2023 | -4,979.00 |
| Sep 30, 2023 | 328.00 |
| Jun 30, 2023 | 2,540.00 |
| Mar 31, 2023 | 2,414.00 |
| Dec 31, 2022 | 985.00 |
| Sep 30, 2022 | 4,410.00 |
| Jun 30, 2022 | 98.00 |
| Mar 31, 2022 | 205.00 |
| Dec 31, 2021 | -802.00 |
| Sep 30, 2021 | 2.00 |